Here we identify a new regulator of endocytosis called RME-6. RME-6 is evolutionarily conserved among metazoans and contains Ras-GAP (GTPase-activating protein)-like and Vps9 domains. Consistent with the known catalytic function of Vps9 domains in Rab5 GDP/GTP exchange, we found that RME-6 binds specifically to Caenorhabditis elegans RAB-5 in the GDP-bound conformation, and rme-6 mutants have phenotypes that indicate low RAB-5 activity. However, unlike other Rab5-associated proteins, a rescuing green fluorescent protein (GFP)-RME-6 fusion protein primarily localizes to clathrin-coated pits, physically interacts with α-adaptin, a clathrin adaptor protein, and requires clathrin to achieve its cortical localization. In rme-6 mutants, transport from the plasma membrane to endosomes is defective, and small 110-nm endocytic vesicles accumulate just below the plasma membrane. These results suggest a mechanism for the activation of Rab5 in clathrin-coated pits or clathrin-coated vesicles that is essential for the delivery of endocytic cargo to early endosomes.
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. These processes are highly regulated but the precise molecular mechanisms controlling these steps are not fully understood.
Small GTPases of the Rab family have pivotal roles in vesicular transport 2 . Rab5 in particular is known as a key regulator of the early endocytic pathway. Rab5 is found associated with the plasma membrane, CCVs, and most prominently with early endosomes 3, 4 . Rab5 is thought to regulate homotypic fusion of early endosomes, microtubule-based motility of early endosomes, and the organization of subdomains within the early endosome-limiting membrane, through its ordered recruitment of multiple effectors to the endosomal periphery [5] [6] [7] [8] . In vitro studies also indicate that Rab5 regulates heterotypic fusion of CCVs with early endosomes, and in complex with GDP dissociation inhibitor (GDI), Rab5 has been proposed to function in ligand sequestration during clathrin-coated pit formation [9] [10] [11] . To exert such diverse functions, the activity of Rab5 must be spatially and temporally controlled, probably at the level of nucleotide exchange by guanine nucleotide-exchange factors (GEFs). Rabex-5 is the canonical Rab5 GEF and is essential for Rab5-dependent fusion of early endosomes in vitro 9 . Studies on the catalytic function of Rabex-5 revealed that the conserved Vps9 domain is necessary and sufficient for the observed enhancement of Rab5 GDP/GTP exchange rates by . In mammals, Rab5 GEF activity has also been biochemically demonstrated for two other Vps9-domain proteins, Rin1 and Alsin, suggesting that Rab5 is regulated by multiple GEFs in vivo 13, 14 . Rab5 GEF activity that is associated with CCVs has also been identified in vitro, but the particular protein that confers this activity remains to be determined 15 .
Here we report molecular cloning and functional characterization of RME-6, an evolutionarily conserved protein that contains both Ras-GAP-related and Vps9 domains. Our results demonstrate that RME-6 is a key regulator of RAB-5 that is required for endocytosis from the plasma membrane.
RESULTS

rme-6 mutants show endocytosis defects in oocytes and coelomocytes
We isolated four alleles of rme-6 in a previously reported genetic screen for mutants that were defective in oocyte endocytosis of YP170-GFP, a reporter for clathrin-dependent endocytosis in C. elegans 16 . In these rme-6 mutants, YP170 uptake by oocytes was strongly reduced, resulting in accumulation of YP170-GFP in the body cavity and very little YP170-GFP in the oocytes (RME phenotype; Fig. 1d ). Seven alleles of rme-6 were also identified in a different genetic screen for coelomocyte endocytosis mutants 17 ( Fig. 1e ). As shown in Fig. 1f , rme-6 mutants exhibit high-level accumulation of a fluid-phase endocytosis marker (GFP secreted by muscle; ssGFP) in the body cavity, indicating a severe defect in endocytosis by coelomocytes. These phenotypes in oocytes and coelomocytes suggest that rme-6 is generally required for endocytosis in multiple tissues.
A R T I C L E S rme-6 encodes a conserved protein with Ras-GAP-like and Vps9 domains
We cloned the wild-type rme-6 gene using standard methods and identified sequence changes associated with each of the rme-6 alleles ( Fig. 1g and see Supplementary Information, Fig. S1 ; see also Methods). The rme-6 gene encodes a novel 1,093-amino-acid protein (Fig. 1g) . The most notable feature of the predicted RME-6 sequence is a Vps9 domain at the carboxyl terminus, a motif found in the catalytic domains of Rab5 GEFs including human Rabex-5 and Rin1, and yeast Vps9p (ref. 12) . In addition to the Vps9 domain, RME-6 contains a Ras-GAP-related domain in the amino-terminal region 18 . We found predicted fly and mammalian homologues of RME-6 in genome databases, and the overall domain structure is well conserved among them. The C. elegans genome has a homologue of Rabex-5, the canonical Rab5 GEF, which is encoded by Y39A1A.5/rabx-5 on chromosome III. Human and worm Rabex-5 proteins show a characteristic domain structure, including an N-terminal zinc-finger domain and a central Vps9 domain. RME-6 and Rabex-5 share sequence similarity only within a limited region comprising primarily the Vps9 domain (see Supplementary  Information, Fig. S1 ). Thus, RME-6 is a new Vps9-domain-containing protein that is conserved from worm to human (Fig. 1h) .
The N-terminal Ras-GAP-like sequence is highly conserved among RME-6 proteins, implying an important function for this domain (see Supplementary Information, Fig. S1 ). Similar GAP-related domains are found in the family of GAPs specific for Ras, such as human p120-GAP and C. elegans GAP1 and GAP2 (refs 18-20) . This motif is also found in IQ-GAP proteins, which lack GAP activity towards Ras but are known to instead interact with Rac and Cdc42 (ref. 21) . Interestingly, this domain within RME-6 shows the highest similarity with IQ-GAP (see Supplementary Information, Fig. S1 ). Ce.RME-6
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(a-d) YP170-GFP endocytosis by oocytes of adult hermaphrodites. In wild type, YP170-GFP is efficiently endocytosed by oocytes (c). In the rme-6(b1014) mutant, endocytosis of YP170-GFP by oocytes is greatly reduced and most YP170-GFP accumulates in the body cavity (d). Nomarski images of the same fields are shown in a and b. Arrows indicate oocytes. SP, spermatheca. (e, f) Coelomocyte endocytosis assay using GFP that was secreted from body-wall muscle cells. Secreted GFP is taken up by coelomocytes and accumulates in vesicles of wild-type coelomocytes (e). In rme-6(ar507), strong accumulation of GFP in the body cavity was observed, indicating poor endocytosis by coelomocytes (f). Some secreted GFP does accumulate within the coelomocytes of rme-6 mutants, but the vesicles that are labelled by the internalized GFP are abnormally small (see Results). Cell boundaries of coelomocytes are outlined. Cc, coelomocyte. Scale bars in c-f, 10 µm. (g) Domain structure of RME-6, showing the N-terminal Ras-GAP-related domain and the Vps9 domain at the C terminus. Mutations identified in each of the 11 rme-6 alleles are also shown, including three mis-sense mutations (in bold). (h) Phylogenic analysis of Vps9 domain proteins. Amino-acid sequences of indicated proteins were analysed by ClustalW. Ce, Caenorhabditis elegans; Hs, Homo sapiens; Dm, Drosophila melanogaster; Sc, Saccharomyces cerevisiae. Bold text represents the RME-6 family. (i) Detection of RME-6 protein. Total lysates were prepared from wildtype and rme-6(b1014) worms and examined by immunoblotting using anti-RME-6 antibodies. Asterisk, nonspecific band. . (a) Two-hybrid assay between RME-6 and RAB-5. Full-length RME-6 was expressed in a yeast reporter strain as a fusion with the DNA-binding domain of LexA (bait). Fulllength C. elegans RAB-5, RAB-7 and their mutant forms were expressed in the same yeast cells as fusions with the transcriptional activation domain of B42 (prey). Interaction between bait and prey was tested using the LEU2 reporter gene (data shown) and β-galactosidase (data not shown) reporter assays. WT, wild type. (b) Co-immunoprecipitation of GFP-RME-6 and HA-RAB-5, or their mutant forms, co-expressed in COS-7 cells. HA-RAB-5 was immunoprecipitated with anti-HA antibody and precipitants were analysed by immunoblotting using anti-GFP antibody. Aliquots of total cell lysates were also examined by immunoblotting using anti-HA and anti-GFP antibodies.
A R T I C L E S
We detected a protein of the predicted size for RME-6 with a relative molecular mass of 130,000K (M r 130K) in wild-type worm lysates by immunoblotting using an affinity-purified anti-RME-6 antibody that we developed (Fig. 1i) . The 130K band is missing from rme-6(b1014)-null mutant lysates.
RME-6 interacts with a predicted GDP-bound form of RAB-5
Rab5 is known as the key regulator of early endocytic events in mammalian systems 4, 6 . We have also previously demonstrated that RAB-5 is required for endocytosis in C. elegans 16 . The existence of the Vps9 domain in RME-6 led us to speculate that RME-6 regulates endocytosis through activation of RAB-5. To test this hypothesis, we first examined physical interaction between RME-6 and RAB-5 using yeast two-hybrid analysis (Fig. 2a) . Similar to previously reported results for known Rab5 exchange factors 13, 22 , RME-6 specifically interacted with RAB-5 S33N , which is a mutant form of RAB-5 that is expected to be locked in the GDP-bound conformation. No interaction was detected with the wild-type or GTPase-defective mutant RAB-5 Q78L in this assay. Moreover, this interaction was specific for RAB-5 because RME-6 showed no interaction with RAB-7 or its mutant forms.
Physical interaction between RME-6 and RAB-5 was further confirmed by co-immunoprecipitation analysis in transfected COS cells. GFP or a fusion of GFP and C. elegans RME-6 were co-expressed in COS-7 cells together with haemagglutinin (HA)-tagged C. elegans RAB-5 or its mutant forms. HA-RAB-5 was immunoprecipitated from total cell lysates using an anti-HA antibody. Precipitants were probed with anti-GFP antibody on western blots (Fig. 2b) . We observed significant co-immunoprecipitation of GFP-RME-6 with all three forms of HA-RAB-5. Consistent with the result of the two-hybrid assay, by far the strongest interaction we observed was between GFP-RME-6 and HA-RAB-5
S33N
, even though the HA-RAB-5 S33N mutant expressed poorly in COS-7 cells compared with the other HA-RAB-5 forms. No interaction was detected between GFP alone and any form of HA-RAB-5, indicating the specificity of the interaction. The preferential interaction of RME-6 with the GDP-bound RAB-5 in two different assays strongly suggests that RME-6 functions as a GEF for RAB-5. RME-6 and C. elegans Rabex-5 are partially redundant for membrane localization of RAB-5 and animal viability The phenotypes we have described here for rme-6 mutants are very similar to those we previously described for rab-5(RNAi), except that loss 
A R T I C L E S
of rab-5 activity is lethal, whereas loss of RME-6 is not 16 . We speculated that this difference might result from residual RAB-5 activation in rme-6 mutants mediated by RABX-5, the apparent worm orthologue of . In mammalian systems, Rabex-5 is found in a stable complex with Rabaptin-5, a Rab5 effector protein 9, 23 . It has been proposed that Rabex-5 and Rabaptin-5 require one another for function. The C. elegans genome contains a putative worm Rabaptin-5, F01F1.4/rabn-5. And indeed, we found that worm RABX-5 can interact with the putative worm Rab5 effector RABN-5 as well as GDP-bound RAB-5 in yeast twohybrid assays (see Supplementary Information, Fig. S2 ). These results suggest that a functional RABX-5-RABN-5 complex exists in worms, similar to the well-studied Rabex-5-Rabaptin-5 complex in mammals.
Surprisingly, neither rabx-5(RNAi) nor rabn-5(RNAi) had significant effects on YP170-GFP endocytosis by oocytes, ssGFP endocytosis by coelomocytes, or on animal viability ( Fig. 3e ; data not shown). We also observed normal YP170-GFP endocytosis by oocytes in a rabx-5(tm1512) mutant that lacked RABX-5 protein, as assayed by immunoblotting (see Supplementary Information, Fig. S2 ).
Unlike either single mutant, however, RNA interference (RNAi) of rabx-5 or rabn-5 in an rme-6(b1014) mutant background resulted in strong synthetic lethality (Fig. 3e) . Many of the arrested larvae showed a moulting defective phenotype often associated with worms that are severely compromised for endocytic function 24, 25 . These synthetic phenotypes indicate a partial redundancy between RME-6 and the RABX-5-RABN-5 complex for endocytic function.
If RME-6 functions as a RAB-5 GEF, we would expect to observe phenotypic effects in rme-6 mutants that reflect low RAB-5 activation. In an effort to identify such defects, we examined the effect of rme-6 mutations and/or rabx-5 mutations or RNAi on the subcellular localization of GFP-RAB-5 expressed in oocytes. In wild-type oocytes, GFP-RAB-5 is mainly localized to endosomes with a punctate appearance in the cortex (Fig. 3a) . In rme-6(b1014), the size of these GFP-RAB-5-positive structures was reduced by an average of about threefold (Fig. 3b, f) . This phenotype is consistent with decreased membrane influx into endosomes or a defect in homotypic endosome fusion. Mutation or RNAi of rabx-5 produced a similar reduction in the size of GFP-RAB-5-positive endosomes, but did not affect YP170-GFP endocytosis per se, consistent with a defect in homotypic endosome fusion (Fig. 3c, f) . Strikingly, the punctate pattern of GFP-RAB-5 completely disappeared in rme-6(b1014) mutants that were depleted of rabx-5 by RNAi (Fig. 3d) . Instead, in oocytes that lack RME-6 and RABX-5, GFP-RAB-5 appeared diffuse in the cytoplasm. By anti-GFP immunoblotting, we confirmed that the GFP-RAB-5 protein levels were not affected by the mutations or RNAi depletions (Fig. 3e) . Taken together, these results indicate that RAB-5 function is severely (a) TR-BSA was microinjected into the body cavity, and endocytic transport of TR-BSA in coelomocytes was observed at different time points after injection. To visualize endosomes within coelomocytes, transgenic worms that express RME-8-GFP were used. In wild type, TR-BSA first appeared inside RME-8-GFP-positive endosomes 5 to 10 min after injection (arrowheads). After 30 min, TR-BSA began to accumulate in the RME-8-GFP-negative lysosomes (small arrows). (b) The same time course of TR-BSA uptake by coelomocytes was analysed in rme-6(b1014) mutants that express the RME-8-GFP endosome marker. At early time points, TR-BSA showed a diffuse pattern close to the plasma membrane (large arrows). Significant overlap between TR-BSA and RME-8-GFP signals was observed during the 30 and 60 min time points (arrowheads). Finally, TR-BSA accumulated in RME-8-GFP-negative compartments 120 min after injection (small arrows).
impaired in rme-6 mutants, and that all or most of the residual RAB-5 activity in rme-6 mutants is mediated by RABX-5.
A very early step of endocytosis is blocked in rme-6 mutants To better understand which step of endocytosis is impaired in rme-6 mutants, we performed pulse-chase analysis of endocytosis in coelomocyte cells using a previously established assay 24 . In this assay, transport of Texas-Red-labelled BSA (TR-BSA) microinjected into the body cavity was followed as a function of time. To visualize better endosomes during endocytosis, our analysis was performed in transgenic animals that express the endosome marker RME-8-GFP 24 . In wild type, we first observed TR-BSA in the RME-8-GFP-positive endosomes 5 to 10 min after injection of the tracer into the body cavity ( Fig. 4a;  arrowheads) . By 30 min after injection, TR-BSA began to leave the endosomes and accumulate within RME-8-GFP-negative lysosomes ( Fig. 4a; arrows) . In rme-6(b1014) mutants, the earliest visible accumulation of TR-BSA in coelomocytes was abnormal and greatly retarded. At early time points, TR-BSA was often observed as a weak signal in an RME-8-negative region of the coelomocyte, very close to the plasma membrane ( Fig. 4b ; large arrows). Because internalization of TR-BSA into coelomocytes is a vesicle-mediated process, we assume that this diffuse TR-BSA signal represents clusters of small vesicles that have accumulated in rme-6 mutant coelomocytes. Concentration of TR-BSA within RME-8-GFP-labelled endosomes became visible 30 to 60 min after injection ( Fig. 4b; arrowheads) . TR-BSA finally reached the terminal compartment of the coelomocytes 60-120 min after injection. These results suggest that the primary defect in rme-6 mutants is during a very early step of endocytosis. (a-d) Immunoelectron microscopy of endogenous yolk receptors (RME-2) was performed in wild type (a) and rme-6(b1014) mutants (b-d). RME-2 localizes to the plasma membrane (PM), small tubulovesicular membranous elements (large arrows) and larger, more electron-dense vesicles (small arrows) in wild-type oocytes (see Results). In rme-6 mutants, RME-2 yolk receptors are observed on grape-like chains of small vesicles (arrowheads).
Images of rme-6 mutants at high magnification are shown in c (boxed region in b) and d (a different field). Scale bars, 200 nm. (e) Quantitative analysis of RME-2 distribution. RME-2-positive structures were classified as vesicles that are smaller or larger than 120 nm in diameter, as plasma membrane or as tubulo-vesicular structures. The number of particles associated with these structures was counted in wild-type (823 particles in total) and rme-6 mutant (773 particles in total) oocytes.
We also sought further evidence to define the primary defect in rme-6 mutant oocytes. To do this we determined the distribution of the yolk receptor RME-2 (ref. 16 ) in oocytes by immunoelectron microscopy (Fig. 5) . Because RME-2 constantly cycles between the plasma membrane and endosomes, most RME-2 in wild-type oocytes at steady state is found in cortical endocytic membrane structures (Fig. 5a ). We detected RME-2 mainly in two types of vesicles in the wild type. The vesicles of one class showed variable size that ranged from 120 to 250 nm and probably represents early or sorting endosomes ( Fig. 5a; small arrows) . The vesicles of the second class are very small, less than 50 nm in diameter and appear to be cross-sectional views of tubulo-vesicular structures, probably recycling endosomes ( Fig. 5a; large arrows) .
Strikingly, in rme-6(b1014), most yolk receptors accumulate very near the plasma membrane in clusters of vesicles that may be docked with one another (Fig. 5b-d; arrowheads in panel b) . The diameter of these vesicles was quite uniform at approximately 110 nm, very close to the known size of CCVs in other systems. In wild-type oocytes, clusters of such vesicles were never observed. We found that, in the rme-6 mutant, 38% of total gold particles were detected associated with these clusters of small vesicles that are less than 120 nm in diameter, and only 6% of particles were found on endocytic structures that were larger than 120 nm (Fig. 5e ). In the wild type, RME-2 was almost equally distributed among small and large endocytic vesicles (Fig. 5e) . We consider it likely that the accumulated clusters of vesicles in rme-6 mutants are intermediates of plasma membrane to early endosome transport and may be uncoated primary endocytic vesicles. Combined with the defects we observed in pulse-chase experiments in coelomocytes, these results indicate a very early role for RME-6 in endocytosis.
GFP-RME-6 colocalizes with clathrin-coated pit markers To understand better the function of RME-6 in endocytosis, we determined its subcellular localization. To this end, we created transgenic worms that expressed RME-6 with either N-or C-terminal GFP tags, each under the control of the rme-6 promoter. Expression of these RME-6 fusion proteins fully rescues the coelomocyte endocytosis defect of rme-6(b1014), indicating that both GFP fusions are functional and are very likely to be correctly localized (see Supplementary Information, Fig. S3 ). GFP-RME-6 was expressed in many tissues ( Fig. 6a-d ; data not shown). Interestingly, in intestinal and pharyngeal cells, GFP-RME-6 was clearly concentrated on the plasma membrane. In coelomocytes, GFP-RME-6 was also localized on or very close to the plasma membrane.
To define the subcellular localization of RME-6, we first performed double labelling of GFP-RME-6 and monomeric red fluorescent protein (mRFP)-tagged RME-6 with endocytic compartment markers in coelomocytes. In coelomocytes we focused on two markers for plasma membrane clathin-coated pits: clathrin heavy chain (CHC-1) and α-adaptin (APT-4), and two markers for early endosomes: EEA-1 and RAB-5 ( Fig. 7b-d and see Supplementary Information, Fig. S4a) .
Most GFP-RME-6 did not overlap with mRFP1-EEA-1 or mRFP1-RAB-5. In contrast, we found strong colocalization of GFP-RME-6 with mRFP1-CHC-1 and mRFP1-α-adaptin on or near the plasma membrane of coelomocytes. Interestingly, mRFP1-CHC-1 and mRFP1-α-adaptin as well as GFP-RME-6 were distributed unevenly around the plasma membrane, with regions of high and low labelling, reminiscent of the uneven distribution of endocytic pit structures that can be seen in coleomocytes by electron microscopy 26 . We observed similar colocalization with mRFP-RME-6 and GFP-CHC-1, a tagged form of worm CHC-1 that has been extensively studied before 25 (Fig. 7a) . These results indicate that most RME-6 is associated with clathrin-coated pits and that only a minor fraction of the RME-6 in the cells is associated with early endosomes.
We observed similar subcellular localization of GFP-RME-6 in oocytes and the hypodermis. To analyse RME-6 distribution in oocytes, we established strains that express GFP-RME-6 in the rme-6(b1014) background under pie-1 promoter control 27, 28 . Expression of GFP-RME-6 in oocytes completely rescued the yolk endocytosis defect of the rme-6(b1014)-null mutant. We found that GFP-RME-6 was concentrated on small puncta, which were on or close to the plasma membrane of oocytes (Fig. 6e, f) . We observed strong colocalization of this GFP-RME-6 with mRFP1-CHC-1 surface puncta, indicating that RME-6 labels coated pits or vesicles (Fig. 7e) . On the other hand, GFP-RME-6 in oocytes showed little spatial overlap with endogenous EEA-1, as assayed using a previously published anti-EEA-1 antibody 43, 45 (see Supplementary  Information, Fig. S4b ). Clear colocalization of GFP-RME-6 and mRFP-CHC-1 was also evident in hypodermal cells (Fig. 7f) . We noted that RME-6 and coated pit marker colocalization was not perfect and that the ratio of intensities of GFP-RME-6 and mRFP1-CHC-1 varied from a b e f c d Figure 6 Expression and subcellular localization of GFP-RME-6 in worm tissues.
(a-d) Expression of a rescuing GFP-RME-6 fusion protein in live animals under rme-6 promoter control. Expression was observed in pharynx (a), intestine (b), neurons (arrows in a and c) and coelomocytes (d). (e, f) A rescuing GFP-RME-6 fusion protein expressed in oocytes under pie-1 promoter control. Dissected gonads of the transgenic worms were stained with an anti-GFP monoclonal antibody. GFP-RME-6 is enriched in cortical puncta of oocytes. The middle (e) and surface (f) of oocytes are shown. In f, an enlarged image of the boxed region is shown in the inset. Scale bars, 10 µm.
puncta to puncta, implying that GFP-RME-6 may associate with clathrin-coated pits at a specific stage in their formation. This colocalization of GFP-RME-6 with clathrin-coated pit markers suggests that the primary function of RME-6 is to activate RAB-5 on the plasma membrane and in coated pits, a location where mammalian Rab5 is found and has been suggested to function, but for which a Rab5 activation mechanism has remained obscure.
Clathrin is required for the cell-surface localization of GFP-RME-6
If RME-6 is localized by association with clathrin-coated pits, then we would expect that removal of these structures would disrupt RME-6 localization. Indeed, we found that RNAi-mediated knockdown of CHC-1, but not RAB-5, disrupts the cortical localization of GFP-RME-6 in oocytes ( Fig. 8a-d) . Under the conditions used, RNAi of either chc-1 or rab-5 blocked yolk uptake and resulted in embryonic lethality, indicating that the RNAi-mediated depletions worked efficiently. In chc-1(RNAi) animals, cortical GFP-RME-6 in oocytes disappeared almost completely (27 out of 30 animals assayed). Thus the cortical localization of GFP-RME-6 depends upon clathrin. RNAi of rab-5 did not reduce the cortical localization of GFP-RME-6, but in many animals the GFP-RME-6 cortical localization appeared more concentrated compared with control worms. RNAi treatment using rab-7 or non-specific DNA fragments showed no obvious effect on GFP-RME-6 localization (data not shown).
RME-6 interacts physically with a clathrin adaptor protein
These results suggest a physical interaction between RME-6 and clathrin-coated pit components in vivo. To test this possibility we performed co-immunoprecipitation experiments between GFP-tagged RME-6 and endogenous α-adaptin from whole-worm lysates (Fig. 8e, f) . We found that α-adaptin did indeed co-immunoprecipitate with GFP-RME-6, showing a physical link between RME-6 and clathrin-coated pits.
DISCUSSION
Here we identify and provide in vivo relevance for a key new Rab5 regulator that is closely associated with the clathrin-coated pit. In mammalian systems, Rab5 is known as a rate-limiting regulator of early endocytic events 4 . Rab5 is found on the plasma membrane and in coated pits as well as on early endosomes 3, 4 . Overexpression of a dominant-negative form of Rab5 inhibits uptake of endocytic cargo into cells 4, 29 and causes accumulation of cargo in coated pits 30 . Despite this mounting evidence for Rab5 function in coated-pit-mediated internalization, most known Rab5-associated proteins localize to and function in early endosomes, and the functional importance and activation mechanism for Rab5 in coated pits has remained obscure 5, 6, 23, 31 . Our detailed phenotypic analyses and the coated-pit association of RME-6 presented here indicate a primary function for RME-6 in activating RAB-5 in clathrin-coated pits and/or primary endocytic vesicles. In particular, we found by immunoelectron microscopy that in the absence of RME-6 function, oocyte cells accumulate clusters of 110-nm vesicles that contain receptors, suggesting that fusion of endocytic vesicles with one another and with early endosomes is severely impaired. Consistent with previous analysis of Rab5 function in vitro 11 , rme-6 mutants do not show any obvious defects in coated pit size or number (data not shown), suggesting that the formation of clathrin-coated pits per se does not require RME-6 or RAB-5.
In vitro fusion assays of CCVs and early endosomes indicate that Rab5 is necessary on both donor and target membranes 10 . However, EEA1 and hVps34, known Rab5 effectors involved in early endosome fusion are absent from CCVs 10 . Such asymmetric localization of downstream effectors has been proposed to be important for directional transport. GFP-RME-6 colocalizes strongly with clathrin-coated pit markers.
(a) Colocalization of mRFP-RME-6 and GFP-CHC-1 in coelomocytes.
(b-d) Subcellular localization of GFP-RME-6 and organeller markers in coelomocytes. GFP-RME-6 and the indicated mRFP1 fusions were coexpressed in coelomocytes. Strong colocalization was observed between GFP-RME-6 and α-adaptin/APT-4 (b). GFP-RME-6 only weakly colocalized with early endosome markers mRFP-EEA-1 (c) and mRFP-RAB-5 (d).
(e, f) Colocalization of GFP-RME-6 and mRFP1-CHC-1 in the cortex of oocytes (e) and hypodermal cells (f; hyp) in an rme-6(b1014) background. Scale bars, 2 µm.
A R T I C L E S
How can asymmetric recruitment of Rab5 effectors to CCVs or early endosomes be achieved? One possibility is that activation of Rab5 by different GEFs is coupled with recruitment of a distinct set of downstream Rab5 effectors. CCVs have been reported to possess Rab5 GEF activity, although the molecular nature of this activity has not been elucidated 15 . Our results suggest that RME-6 is such an activator of RAB-5 on clathrin-coated pits and/or CCVs, and could be the activity that was detected previously by others.
The coated-pit association of RME-6 suggests that RAB-5 is recruited and activated before or during coated-vesicle formation. It has been shown that the Rab5-GDI complex enhances sequestration of cargo into clathrin-coated pits in vitro, and that GDP/GTP exchange of Rab5 is necessary for this activity 11 . RME-6 may be involved in cargo selection at the plasma membrane, although it is difficult to directly address this issue in the C. elegans system. Alternatively, Rab5 may be recruited before vesicle formation to ensure formation of fusion-competent vesicles. This second model would best explain the phenotypes that we observed in rme-6 mutants. The reduction in endosome size without an obvious reduction in overall endocytic transport in rabx-5 mutants or RNAitreated animals is most consistent with a role for rabx-5 in homotypic endosome fusion, and may indicate that homotypic endosome fusion is not strictly required for endocytosis per se. It is also interesting to note that others have found that Rabaptin-5 in complex with Rabex-5 binds to γ-adaptin and GGA1, clathrin adaptor molecules that are involved in trans-Golgi network (TGN)-to-endosome transport 32, 33 . Thus, recruiting Rab5 GEFs to donor vesicles by interaction with coat proteins could be a general mechanism for activation of Rab5 on vesicles that ensures subsequent fusion with acceptor membranes.
The physical interaction that we demonstrated between RME-6 and α-adaptin could be direct or could be mediated by bridging proteins, and awaits further analysis. We note, however, that within the Vps9 domain of RME-6 there is a sequence similar to a known α-adaptin ear-binding motif, WxxF (RME-6; 1079WVNF) 34 . Rabex-5 forms a stable complex with Rabaptin-5, one of the known Rab5 effectors, and also exists as part of a large oligomeric EEA1-positive complex on early endosomes 6, 9 . Interestingly, RME-6 seems not to interact with C. elegans Rabaptin-5 (RABN-5) in two-hybrid assays (our unpublished observation) or with EEA-1 in co-immunoprecipitation assays (Fig. 8e) . These results support the idea that RME-6 and Rabex-5-dependent activation of Rab5 are responsible for the regulation of different sets of downstream effectors. The fact that loss of RME-6 or RABX-5 alone results in reduced endosome size, but only loss of RME-6 impairs ligand uptake by endocytosis further supports the idea that RME-6 has a primary function in uptake from the plasma membrane whereas RABX-5 probably functions primarily in homotypic endosome fusion. However, the synthetic phenotypes we uncovered when worms lack both rme-6 and rabx-5 activity indicate that when RME-6 is missing, RABX-5 can partially substitute at the plasma membrane.
In addition to the Vps9 domain, RME-6 family members have a Ras-GAP-related domain near their N termini that may modulate RME-6 function in response to a signalling pathway and/or may function to send signals that are derived from RAB-5. Our preliminary analysis has failed to identify genetic or physical interactions between RME-6 and LET-60, the canonical C. elegans Ras 35 . We deem it likely that RME-6 instead interacts with another member of the Ras family, or that it interacts with a Rho-family GTPase, as in the case for IQ-GAP1, another protein with a Ras-GAP-like domain 21 .
To elucidate the precise function of RME-6 and Rab5 in coated pits and to identify putative effectors that are involved in this process, it will be important to determine the function of the N-terminal domain of RME-6 and identify additional proteins that function with RME-6 in endocytosis.
METHODS
General methods and strains. C. elegans strains were derived from the wild-type Bristol strain N2. Worm cultures, genetic crosses and other C. elegans methods were performed according to standard protocols 36 . Strains expressing transgenes in germline cells were grown at 25 °C. Other strains were grown at 20 °C. Transgenic strain bIs1(vit-2::GFP) expressing a fusion of YP170, a yolk protein and GFP was used to monitor yolk uptake by oocytes 16 . Coelomocyte endocytosis was assayed using arIs37(pmyo-3::ssGFP) or cdIs5(pmyo-3::ssDsRed2) 17, 37 . A deletion allele of rabx-5(tm1512) was provided by S. Mitani of the Japanese National Bioresource Project for nematodes. This mutant lacks 983 bp of the rabx-5 gene -including GFP−RME-6 GFP−RME-6 α-adaptin α-adaptin Figure 8 Physical and functional association of RME-6 and coated-pit proteins. (a-d) RNAi-mediated knockdown of clathrin heavy chain but not rab-5 disrupts the cortical localization of GFP-RME-6 in oocytes. RNAi of rab-5 (a) or chc-1 (b) was performed in worms that express GFP-RME-6 in oocytes. P 0 worms were grown on RNAi bacteria for 24 h at 25 °C. Fluorescence intensity as a function of position was graphed using Metamorph software along the lines indicated in panels c and d for a and b, respectively. Arrows indicate the relative position of oocyte plasma membranes. (e, f) GFP-RME-6 and α-adaptin co-immunoprecipitate from whole-worm lysates. Total lysates were prepared from worms that express GFP-RME-6 in an rme-6(b1014) background and subjected to immunoprecipitation with anti-GFP antibody (e) or anti-α-adaptin antibody (f). Precipitants were probed by immunoblotting with anti-α-adaptin and anti-EEA-1 antibodies (e) or anti-GFP antibody (f). T (total lysate) equals approximately 1.5% of the total input into the assay.
A R T I C L E S
the second exon and a part of the third exon (nucleotides 8810/8811-9793/9794 in the cosmid Y39A1A) -which deletes part of the coding region. This is expected to cause a frameshift that places all downstream coding regions, including the catalytic vps9 domain, out of frame. This mutation was followed through genetic crosses by PCR using the primers rabx5-F (5′-ATTCCCCCAGATTGTGTATG-3') and rabx5-R (5′-CCGGTGACGTGGAAGTTGGT-3′ 24, 25 . RNA interference was performed by the feeding method 38 . cDNAs were prepared from EST clone provided by Y. Kohara (National Institute of Genetics, Japan) and subcloned into RNAi vector L4440 (ref. 39) . For RNAi knockdown, larval stage 4 (L4) worms were placed onto RNAi plates, and P 0 adults (after 24 h) or F 1 progeny (after 3 to 4 days) were subsequently scored for phenotype.
Genetic mapping and molecular cloning. b1014, b1015, b1018 and b1019ts were isolated in a screen described previously 16 . Briefly, bIs1(vit-2::GFP) was mutagenized with ethylmethane sulphonate (EMS) or N-ethyl-N-nitrosurea (ENU), and the F 2 generation was screened for animals that exhibited little or no GFP signal in oocytes and embryos but that showed bright GFP signals in the body cavity. ar471, ar474, ar476, ar477, ar483, ar507 and ar511 were identified in unrelated screening for coelomocyte endocytosis-defective mutants and generously provided to us by H. Fares and I. Greenwald 17 . All rme-6 mutations are recessive and most of them show constitutive endocytosis defects at all temperatures tested. Only b1019 shows a temperature-sensitive defect in YP170-GFP endocytosis by oocytes. rme-6 mutant worms also show slow growth and small body size at all temperatures, and a low brood size at 25 °C (N2, 204 ± 23; rme-6(b1014), 67 ± 11 (s.d.)).
The rme-6 mutations were mapped to the left-hand side of chromosome X by sequence-tagged site polymorphism mapping 40 . Tight linkage between rme-6 and unc-1 was shown by the following three-point mapping results: egl-17 (11 of 11) rme-6 (0 of 11) unc-1; and unc-1 (0 of 53) rme-6 (53 of 53) dpy-3. The map position of rme-6 was further refined by a complementation test with deficiencies; meDf6 failed to complement rme-6 but meDf2, meDf3 and meDf5 did complement. To identify a candidate for rme-6, we surveyed predicted genes in the C. elegans genomic sequence in this region by RNAi for the RME phenotype. RNAi for one of these genes, F49E7.1a, which encodes a protein with the Vps9 domain, produced a strong RME phenotype that was similar to that of rme-6 mutants. Rescue of the coelomocyte endocytosis defect of an rme-6(b1018);arIs37 strain was achieved by microinjection of a 7.2-kb PCR-amplified DNA fragment including the complete F49E7.1a gene (at 10 µg ml −1 ) together with the dominant transgenic marker rol-6(su1006) (pRF4; 100 µg ml −1 ). All exons from F49E7.1a were amplified from each rme-6 mutant and sequenced. Comparison of these sequences with the wild-type gene revealed a single sequence change for each mutant (ar483(T293A), b1014(C1816T), ar474(C3099T), ar476(G3462A), b1018(G3899A), ar471(G3899A), b1019ts(G4316A), ar477(G4316A), ar511(G4725A), ar507(G5594A) and b1015(T5980A); Fig. 1g ). To determine the precise coding region of rme-6, the apparently full-length cDNA yk629b9 was sequenced (Genbank accession number AY750054).
Plasmids and transgenic strains. To construct GFP::rme-6, the rme-6 promoter region (889 bp) was PCR-amplified with primers that contain BssHII and Asp718I restriction sites, and was cloned into like sites in the C. elegans GFP vector pPD117.01 (gift from A. Fire). The complete coding sequence and 3′ untranslated region (UTR) of rme-6 (7,087 bp) was then PCR-amplified with primers adding SpeI and ApaI restriction sites, and cloned into compatible NheI and ApaI sites downstream of GFP in the same vector. The resulting plasmid (10 µg ml −1 ) was co-injected with pRF4 (100 µg ml −1 ) into N2 to establish multiple transgenic lines. Standard gamma irradiation methods were then used to attach one of these arrays to a chromosome 41 to generate strain RT6: pwIs2. When crossed into an rme-6(b1014) background, pwIs2 fully rescued the coelomocyte endocytosis defect (see Supplementary  Information, Fig. S3 ). To make rme-6::GFP, Gateway Reading Frame Cassette B (Invitrogen, Carlsbad, CA) was inserted into the filled Asp718I site of pPD117.01, which is located upstream of the GFP coding region. The rme-6 gene, including the promoter (864 bp) and the coding region without the stop codon, was amplified by PCR, cloned into pDONR221, and transferred into the modified pPD117.01 by Gateway recombination cloning (Invitrogen). The resulting plasmid was introduced into rme-6(b1014); unc-119(ed3) by the microparticle bombardment together with a marker plasmid MM016B that contains the wild-type unc-119 gene 28 . To test rescuing activity of rme-6::GFP, endocytosis of microinjected Texas-Red-conjugated BSA by coelomocytes was examined as described previously 24 (see Supplementary Information, Fig. S3 ). For germline expression of transgenes, two vectors, pID3.01B and pKS1, were utilized. pID3.01B (ref. 27 ) drives an N-terminal GFP fusion under pie-1 promoter control. pKS1 was made by replacing the coding sequence of GFP in pID3.01B with that of mRFP1 (ref. 42) . Genomic DNA from rme-6 and the worm clathrin heavy-chain gene (chc-1) and a C. elegans rab-5 cDNA were cloned individually into pDONR201 and then transferred into pID3.01B or pKS1 by Gateway recombination cloning. Low-copy integrated transgenic lines were obtained by the microparticle bombardment method 28 . GFP::rme-6 under pie-1 promoter control was directly introduced into the rme-6(b1014) background and examined for rescue of yolk endocytosis.
For coelomocyte expression, pHD43 and pHD82 were used, which express N-terminal GFP and mRFP1 fusions, respectively, under the coelomocyte-specific promoter 43 (gift from H. Fares). Genomic DNA from rme-6, chc-1, worm α-adaptin/apt-4 (T20G5.1) and worm EEA1/eea-1 (T10G3.5) were cloned into pDONR221 and transferred into pHD43 or pHD82 by Gateway cloning. The resulting plasmids were introduced into unc-119(ed3) by the microparticle bombardment together with a marker plasmid MM016B. cdEx142 (pcc1::mRFP::rab-5; pPD118.33) expressing mRFP1::rab-5 under the coelomocyte-specific promoter was kindly provided by H. Fares (University of Arizona, AZ).
We confirmed that expression of these GFP and mRFP fusions does not interfere with endocytic function in coelomocytes and that similar results were obtained with either pair of markers, indicating that these marker fusion proteins are likely to be functional and correctly localized. The CHC-1 markers used in this study fully rescue the viability and endocytosis defects of a temperaturesensitive lethal allele of chc-1 (K.S. and B.D.G., unpublished observations).
For expression in mammalian cultured cells, an rme-6 cDNA was cloned into pDEST53, an expression vector for N-terminal GFP fusions (Invitrogen) using the Gateway cloning system. HA-tagged C. elegans rab-5 and its mutant forms were made by PCR using a 5′ primer that contains the coding sequence of the HA tag just after the start codon. The resulting DNA fragments encoding HA-tagged RAB-5 or its mutant forms were cloned into pcDNA3.1 (Invitrogen). Sequences of coding regions of these constructs were confirmed.
Antibodies. Anti-RME-2, anti-RME-1 and anti-EEA-1 antibodies were described previously 16, [43] [44] [45] . Anti-α-adaptin antibody against the C-terminal region of C. elegans α-adaptin was a gift from Y. Zhang and D. Hirsh. Anti-RME-6 polyclonal antibody was raised against the C-terminal 300 amino acids of RME-6 and affinity purified. C. elegans RABX-5 antibodies were prepared in rabbits against a synthetic peptide (CEIQAINLTSSGNQEHVEEA, corresponding to the extreme C terminus of the protein) coupled to keyhole lympet haemocyanin, and were affinity purified against the same peptide coupled to a solid matrix (Sulfolink kit; Pierce, Rockford, IL) according to the manufacturer's instructions. Mouse anti-HA monoclonal antibody (16B12), mouse anti-GFP monoclonal antibody (3E5), and goat anti-GFP polyclonal antibody conjugated to horseradish peroxidase (HRP) were purchased from Covance Research Products (Berkeley, CA), Q-BIOgene (Carlsbad, CA) and Research Diagnostics (Flanders, NJ), respectively.
Microscopy, immunostaining and pulse-chase analysis in coelomocytes.
Fluorescence images were obtained using an Axiovert 200M (Carl Zeiss MicroImaging Inc., Thornwood, NY) microscope equipped with a digital CCD camera (C4742-95-12ER; Hamamatsu Photonics, Hamamatsu City, Japan) and Metamorph software (Universal Imaging, Downington, PA) and then deconvolved with AutoDeblur software (AutoQuant Imaging, Troy, NY). Confocal images were obtained using a Zeiss LSM510 confocal microscope system (Carl Zeiss MicroImaging). Quantification of images was performed with Metamorph software (Universal Imaging).
To observe live worms expressing transgenes, worms were mounted on agarose pads containing 10 mM levamisol in M9 buffer. Immunostaining of dissected gonad and endocytosis assays of Texas-Red-conjugated BSA (TR-BSA) in coelomocytes was performed as described previously 16, 24 .
